James McIlroy

James McIlroy serves as Chief Executive Officer at EnteroBiotix. EnteroBiotix operates in the research sector with approximately 60.0 employees. EnteroBiotix generates annual revenue of 2500000.0. To date, EnteroBiotix has raised 58563265.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • Our database includes 201,468 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 Squarespace ECommerce Mobile Friendly Google Maps Typekit Google Font API AI

biotechnology research gut health microbiome therapeutics ibs treatment oral therapies clinical trials drug development liver cirrhosis intestinal microbial transfer microbial ecology anaerobic microorganisms high-diversity microbiota stabilized formulations gmp manufacturing safety & efficacy placebo-controlled trials gut microbiome modulation therapeutic innovations ibs-c ibs-d proprietary drying technology microbial characterization patient care transformation full-spectrum microbiome donor programme clinical-stage biotechnology regulatory compliance disease prevention clinical data advanced therapeutics microbiome dynamics pharmaceutical company employment opportunities healthcare solutions innovative healthcare research & development biopharmaceuticals consistency in treatments strategic partnerships biotechnology advancements analytical toolkit clinical evidence patient-centric solutions health technology assessments novel therapeutics microbiome composition wellness programs scientific collaboration healthcare industry clinical pipeline health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like James McIlroy in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at EnteroBiotix.

James McIlroy's Position in the MessageCEO Database

• •James McIlroy is 1 of 1 verified executive contact we track at EnteroBiotix.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12 verified contacts work at research companies in the 60.0 employee range (same size as EnteroBiotix).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach James McIlroy directly?

James McIlroy's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at EnteroBiotix. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does James McIlroy work for?

James McIlroy is Chief Executive Officer at EnteroBiotix, a company in the research sector with 60.0 employees.

Can I pitch or sell to James McIlroy?

As Chief Executive Officer at EnteroBiotix, James McIlroy is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach James McIlroy directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is James McIlroy in?

James McIlroy works in the research industry as Chief Executive Officer at EnteroBiotix. MessageCEO provides verified contact information for executives across all major industries.

Is James McIlroy's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. James McIlroy's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026